Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 144
Selected: 0
NCT IDTitle
NCT03422432Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases
NCT06766058Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy.
NCT05929885Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients
NCT04946968Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers
NCT07428655Acceptability and Feasibility of PSC Model of Serious Illness Communication
NCT00565708Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers
NCT00589238Paclitaxel, Doxorubicin, and Cyclophosphamide With Or Without Carboplatin in Treating Women With Locally Advanced Breast Cancer That Can Be Removed by Surgery
NCT03792867Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma
NCT01228045A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
NCT04087473Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC
NCT06956248Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE)
NCT02806388Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project
NCT03267641Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma
NCT04118114Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors
NCT04738708Telegenetics or In-Person Genetic Counselling
NCT06418412A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC
NCT04027647Phase 2 Study of Dacomitinib in NSCLC
NCT06172595FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma
NCT04104113Health-related Quality of Life-intervention in Survivors of Breast and Other Cancers Experiencing Cancer-related Fatigue Using Traditional Chinese Medicine: The HERBAL Trial
NCT01341834Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
NCT02412267Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)
NCT07241715Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)
NCT00467194Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
NCT03711422Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
NCT02408497Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy
NCT04014309Accessible Cancer Care to Enable Support for Survivors Programme
NCT02850640Cost and Medical Care of Patients With Advanced Serious Illness in Singapore (COMPASS) Study
NCT03188159Vinorelbine in Relapsed Platinum Resistant or Refractory C5 High Grade Serous, Endometrioid, or Undifferentiated Primary Peritoneum, Fallopian Tube or Ovarian Cancer
NCT02548039To Study The Influence Of Genomic Factors On Metabolism And Effects Of Clomiphene In Asian Normogonadotrophic Anovulatory Patients.
NCT02808091Bortezomib With Combination of Gemcitabine, Ifosfamide and Oxaliplatin in Untreated NK/T Cell Lymphoma
NCT00687648Cyclophosphamide, Methotrexate, and Prednisolone With or Without Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer
NCT07133269Care Coach-led Integrated Palliative Surgical Oncology and Rehabilitation Care Model for Advanced Cancer Patients
NCT02435927ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin
NCT05286437Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole
NCT03515174Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO
NCT07745816Effectiveness and Implementation of 'Supportive and Palliative Care Review Kit in Locations Everywhere'
NCT04961632Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376
NCT05517135tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)
NCT05377034Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
NCT07234357Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia
NCT07111130Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer
NCT00690872Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer
NCT01736410A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
NCT04269967A Pilot Tele-rehabilitation Trial for Breast Cancer Survivors
NCT03212937Phase I Trial of Selinexor (KPT-330) and Ifosfamide, Carboplatin, Etoposide (ICE) in Peripheral T-cell Lymphoma
NCT02736305Use of Regorafenib in Recurrent Epithelial Ovarian Cancer
NCT0499518518F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study
NCT06093061Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
NCT00957086Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
NCT01716689Clinical Study of Metronomic Oral Cyclophosphamide in Patients With Advanced Sarcomas